These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease. Conlon BP Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240 [TBL] [Abstract][Full Text] [Related]
5. Molecular physiological characterization of the dynamics of persister formation in Liu S; Huang Y; Jensen S; Laman P; Kramer G; Zaat SAJ; Brul S Antimicrob Agents Chemother; 2024 Jan; 68(1):e0085023. PubMed ID: 38051079 [TBL] [Abstract][Full Text] [Related]
6. High persister cell formation by clinical Liu L; Wang Y; Bojer MS; Andersen PS; Ingmer H Microbiology (Reading); 2020 Jul; 166(7):654-658. PubMed ID: 32427093 [TBL] [Abstract][Full Text] [Related]
7. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. Singh R; Ray P; Das A; Sharma M J Med Microbiol; 2009 Aug; 58(Pt 8):1067-1073. PubMed ID: 19528167 [TBL] [Abstract][Full Text] [Related]
8. Interplay between population dynamics and drug tolerance of Staphylococcus aureus persister cells. Lechner S; Patra P; Klumpp S; Bertram R J Mol Microbiol Biotechnol; 2012; 22(6):381-91. PubMed ID: 23363876 [TBL] [Abstract][Full Text] [Related]
9. Persister formation in Staphylococcus aureus is associated with ATP depletion. Conlon BP; Rowe SE; Gandt AB; Nuxoll AS; Donegan NP; Zalis EA; Clair G; Adkins JN; Cheung AL; Lewis K Nat Microbiol; 2016 Apr; 1():16051. PubMed ID: 27572649 [TBL] [Abstract][Full Text] [Related]
12. A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Mitchell G; Brouillette E; Séguin DL; Asselin AE; Jacob CL; Malouin F Microb Pathog; 2010 Jan; 48(1):18-27. PubMed ID: 19825410 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic tolerance in biofilm persister cells of Staphylococcus aureus and expression of toxin-antitoxin system genes. Karimaei S; Kazem Aghamir SM; Foroushani AR; Pourmand MR Microb Pathog; 2021 Oct; 159():105126. PubMed ID: 34384900 [TBL] [Abstract][Full Text] [Related]
14. Stochastic Variation in Expression of the Tricarboxylic Acid Cycle Produces Persister Cells. Zalis EA; Nuxoll AS; Manuse S; Clair G; Radlinski LC; Conlon BP; Adkins J; Lewis K mBio; 2019 Sep; 10(5):. PubMed ID: 31530676 [TBL] [Abstract][Full Text] [Related]
15. A pursuit of Staphylococcus aureus continues: a role of persister cells. Chang J; Lee RE; Lee W Arch Pharm Res; 2020 Jun; 43(6):630-638. PubMed ID: 32627141 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. Johnson PJ; Levin BR PLoS Genet; 2013; 9(1):e1003123. PubMed ID: 23300474 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic tolerance and the alternative lifestyles of Bui LM; Conlon BP; Kidd SP Essays Biochem; 2017 Feb; 61(1):71-79. PubMed ID: 28258231 [No Abstract] [Full Text] [Related]
18. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of TCA cycle enhances Staphylococcus aureus persister cell formation in stationary phase. Wang Y; Bojer MS; George SE; Wang Z; Jensen PR; Wolz C; Ingmer H Sci Rep; 2018 Jul; 8(1):10849. PubMed ID: 30022089 [TBL] [Abstract][Full Text] [Related]
20. Vancomycin activates σ(B) in vancomycin-resistant Staphylococcus aureus resulting in the enhancement of cytotoxicity. Chen HY; Chen CC; Fang CS; Hsieh YT; Lin MH; Shu JC PLoS One; 2011; 6(9):e24472. PubMed ID: 21912698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]